Results 31 to 40 of about 916 (106)

Building a Robust Investigator‐Initiated Platform: The I‐CARE Experience

open access: yesClinical Pharmacology &Therapeutics, Volume 119, Issue 6, Page 1537-1546, June 2026.
Investigator‐initiated studies that include information collected by patients are rising, but limited data is available on patient and investigator experience in this setting. The I‐CARE cohort included patients with inflammatory bowel disease (IBD) monthly collecting clinical information in 15 countries for up to 6 years.
Julien Kirchgesner   +906 more
wiley   +1 more source

Psychopathy traits and their link to emotion recognition impairments in conduct disorder

open access: yesJCPP Advances, Volume 6, Issue 2, June 2026.
Abstract Background Neurocognitive models suggest that callous‐unemotional (CU) traits in youths with conduct disorder (CD) are linked to emotion recognition impairments, particularly in identifying distress emotions like fear and sadness. However, CD may be accompanied by grandiose‐manipulative (GM) and/or impulsive‐irresponsible (II) traits in ...
Gregor Kohls   +9 more
wiley   +1 more source

Peri‐Implant Soft‐Tissue Phenotype Modification for Refractory Peri‐Implant Mucositis: A 12‐Month Prospective Clinical Study With Ultrasonographic Analysis

open access: yesJournal of Periodontal Research, Volume 61, Issue 5, Page 606-623, May 2026.
Surgical treatment of refractory peri‐implant mucositis with a free gingival graft (FGG) was effective in disease resolution, achieving reductions in probing pocket depth (PPD) and inflammation. Significant gains in mucosal thickness (MT) and keratinized mucosa width (KMW), as well as partial recession coverage and re‐establishment of attached mucosa ...
Shayan Barootchi   +7 more
wiley   +1 more source

In situ monitoring of cell adhesion kinetics using label‐free optical biosensors: Evaluating anticancer potential and selectivity of natural compounds

open access: yesVIEW, Volume 7, Issue 2, April 2026.
The limitations of conventional techniques hinder the identification of natural compounds with anticancer potential in terms of speed, throughput, sensitivity, and capability of continuous monitoring of relevant biological effects. Novel label‐free optical biosensors represent new opportunities in the discovery of drug candidates, eliminating these ...
Beatrix Péter   +10 more
wiley   +1 more source

On extremal cacti with respect to the edge revised Szeged index

open access: yes, 2018
Let $G$ be a connected graph. The edge revised Szeged index of $G$ is defined as $Sz^{\ast}_{e}(G)=\sum\limits_{e=uv\in E(G)}(m_{u}(e|G)+\frac{m_{0}(e|G)}{2})(m_{v}(e|G)+\frac{m_{0}(e|G)}{2})$, where $m_{u}(e|G)$ (resp., $m_{v}(e|G)$) is the number of edges whose distance to vertex $u$ (resp., $v$) is smaller than the distance to vertex $v$ (resp., $u$)
He, Shengjie, Hao, Rong-Xia, Li, Deming
openaire   +2 more sources

Role of Septin7 in mitochondrial dynamics and oxidative metabolism in C2C12 skeletal muscle cells

open access: yesThe Journal of Physiology, Volume 604, Issue 5, Page 1971-1994, 1 March 2026.
Abstract figure legend Knockdown of Septin7 alters the expression of markers responsible for mitochondrial dynamics. Members of the electron transport chain are also affected by diminished Septin7 level resulting in functional changes of mitochondrial respiration. Abstract Mitochondria are dynamic organelles that undergo fusion and fission.
Andrea Telek   +13 more
wiley   +1 more source

Macrophagic Sclerostin Loop2‐ApoER2 Interaction Required by Sclerostin for Cardiovascular Protective Action

open access: yesAdvanced Science, Volume 13, Issue 8, 9 February 2026.
Sclerostin loop2‐ApoER2 interaction in macrophages is required by sclerostin to suppress NF‐κB nuclear translocation and phosphorylation, to promote macrophage conversion into anti‐inflammatory subtypes in atherosclerotic aortas, as well as to prevent atherosclerosis and aortic aneurysm development in ApoE−/− mice. Abstract Therapeutic antibody against
Luyao Wang   +27 more
wiley   +1 more source

Poster Sessions

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Publication Only

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

ePoster

open access: yes
European Journal of Neurology, Volume 33, Issue S1, June 2026.
wiley   +1 more source

Home - About - Disclaimer - Privacy